Literature DB >> 7426325

A drug for improved radiosensitization in radiotherapy.

S Dische, J F Fowler, M I Saunders, M R Stratford, P Anderson, A I Minchinton, M E Lee.   

Abstract

Mesh:

Substances:

Year:  1980        PMID: 7426325      PMCID: PMC2010462          DOI: 10.1038/bjc.1980.213

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  7 in total

1.  Misonidazole-a drug for trial in radiotherapy and oncology.

Authors:  S Dische; M I Saunders; I R Flockhart; M E Lee; P Anderson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1979-06       Impact factor: 7.038

2.  Radiosensitizers of hypoxic cells in solid tumors.

Authors:  J F Fowler; G E Adams; J Denekamp
Journal:  Cancer Treat Rev       Date:  1976-12       Impact factor: 12.111

3.  Hypoxic cell sensitisers in radiotherapy.

Authors:  G E Adams; S Dische; J F Fowler; R H Thomlinson
Journal:  Lancet       Date:  1976-01-24       Impact factor: 79.321

4.  Pharmacokinetic and metabolic studies of the hypoxic cell radiosensitizer misonidazole.

Authors:  I R Flockhart; P Large; D Troup; S L Malcolm; T R Marten
Journal:  Xenobiotica       Date:  1978-02       Impact factor: 1.908

5.  A metabolite of the 2-nitroimidazole misonidazole with radiosensitizing properties.

Authors:  I R Flockhart; P W Sheldon; I J Stratford; M E Watts
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1978-07

6.  Clinical testing of the radiosensitizer Ro 07-0582: experience with multiple doses.

Authors:  S Dische; M I Saunders; M E Lee; G E Adams; I R Flockhart
Journal:  Br J Cancer       Date:  1977-05       Impact factor: 7.640

7.  Pharmacokinetic and tumour-penetration properties of the hypoxic cell radiosensitizer desmethylmisonidazole (Ro 05-Ro-9963) in dogs.

Authors:  R A White; P Workman
Journal:  Br J Cancer       Date:  1980-02       Impact factor: 7.640

  7 in total
  5 in total

1.  Structure-pharmacokinetic relationships for misonidazole analogues in mice.

Authors:  P Workman; J M Brown
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

2.  Radiation sensitization and chemopotentiation: RSU 1069, a compound more efficient than misonidazole in vitro and in vivo.

Authors:  G E Adams; I Ahmed; P W Sheldon; I J Stratford
Journal:  Br J Cancer       Date:  1984-05       Impact factor: 7.640

3.  Enhancement of the effect of cytotoxic drugs by radiosensitizers.

Authors:  W M Martin; N J McNally; J De Ronde
Journal:  Br J Cancer       Date:  1981-06       Impact factor: 7.640

4.  The concentration of desmethylmisonidazole in human tumours and in cerebrospinal fluid.

Authors:  S Dische; M I Saunders; P J Riley; J Hauck; M H Bennett; M R Stratford; A I Minchinton
Journal:  Br J Cancer       Date:  1981-03       Impact factor: 7.640

5.  A comparative investigation of nimorazole and misonidazole as hypoxic radiosensitizers in a C3H mammary carcinoma in vivo.

Authors:  J Overgaard; M Overgaard; O S Nielsen; A K Pedersen; A R Timothy
Journal:  Br J Cancer       Date:  1982-12       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.